| SMOTE for high-dimensional class-imbalanced data L Lusa BMC bioinformatics 14 (1), 106, 2013 | 994 | 2013 |
| Class prediction for high-dimensional class-imbalanced data R Blagus, L Lusa BMC bioinformatics 11, 1-17, 2010 | 288 | 2010 |
| Firth's logistic regression with rare events: accurate effect estimates and predictions?: R. PUHR ET AL. R Puhr, G Heinze, N Nold, L Lusa, A Geroldinger Statistics in Medicine, 2017 | 260 | 2017 |
| Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer M Frattini, G Gallino, S Signoroni, D Balestra, L Lusa, L Battaglia, G Sozzi, ... Cancer letters 263 (2), 170-181, 2008 | 159 | 2008 |
| Limits of predictive models using microarray data for breast cancer clinical treatment outcome JF Reid, L Lusa, L De Cecco, D Coradini, S Veneroni, MG Daidone, ... Journal of the National Cancer Institute 97 (12), 927-930, 2005 | 146 | 2005 |
| Course and outcome of early European Lyme neuroborreliosis (Bannwarth syndrome): clinical and laboratory findings K Ogrinc, L Lusa, S Lotrič-Furlan, P Bogovič, D Stupica, T Cerar, ... Reviews of Infectious Diseases 63 (3), 346-353, 2016 | 140 | 2016 |
| Evaluation of smote for high-dimensional class-imbalanced microarray data L Lusa 2012 11th international conference on machine learning and applications 2, 89-94, 2012 | 132 | 2012 |
| Joint use of over-and under-sampling techniques and cross-validation for the development and assessment of prediction models R Blagus, L Lusa BMC bioinformatics 16, 1-10, 2015 | 122 | 2015 |
| Challenges in projecting clustering results across gene expression–profiling datasets L Lusa, LM McShane, JF Reid, L De Cecco, F Ambrogi, E Biganzoli, ... JNCI: Journal of the National Cancer Institute 99 (22), 1715-1723, 2007 | 116 | 2007 |
| Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients D Mezzanzanica, M Fabbi, M Bagnoli, S Staurengo, M Losa, E Balladore, ... Clinical Cancer Research 14 (6), 1726-1733, 2008 | 111 | 2008 |
| Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancer LA Korde, L Lusa, L McShane, PF Lebowitz, LA Lukes, K Camphausen, ... Breast cancer research and treatment 119, 685-699, 2010 | 110 | 2010 |
| Resting heart rate variability and heart rate recovery after submaximal exercise A Danieli, L Lusa, N Potočnik, B Meglič, A Grad, FF Bajrović Clinical Autonomic Research 24, 53-61, 2014 | 108 | 2014 |
| Improved metabolic control in pediatric patients with type 1 diabetes: a nationwide prospective 12-year time trends analysis K Dovc, SS Telic, L Lusa, N Bratanic, M Zerjav-Tansek, P Kotnik, ... Diabetes technology & therapeutics 16 (1), 33-40, 2014 | 95 | 2014 |
| Treatment of erythema migrans with doxycycline for 10 days versus 15 days D Stupica, L Lusa, E Ružić-Sabljić, T Cerar, F Strle Clinical infectious diseases 55 (3), 343-350, 2012 | 95 | 2012 |
| Coronavirus infections in hospitalized pediatric patients with acute respiratory tract disease M Jevšnik, T Uršič, N Žigon, L Lusa, U Krivec, M Petrovec BMC infectious diseases 12, 1-7, 2012 | 90 | 2012 |
| Gradient boosting for high-dimensional prediction of rare events L Lusa Computational Statistics & Data Analysis 113, 19-37, 2017 | 86 | 2017 |
| miR-342 regulates BRCA1 expression through modulation of ID4 in breast cancer E Crippa, L Lusa, L De Cecco, E Marchesi, GA Calin, P Radice, ... PloS one 9 (1), e87039, 2014 | 76 | 2014 |
| Tick‐borne encephalitis in patients vaccinated against this disease S Lotrič‐Furlan, P Bogovič, T Avšič‐Županc, M Jelovšek, L Lusa, F Strle Journal of internal medicine 282 (2), 142-155, 2017 | 65 | 2017 |
| Detection of human coronaviruses in simultaneously collected stool samples and nasopharyngeal swabs from hospitalized children with acute gastroenteritis M Jevšnik, A Steyer, T Zrim, M Pokorn, T Mrvič, Š Grosek, F Strle, L Lusa, ... Virology journal 10, 1-7, 2013 | 65 | 2013 |
| Suspected early Lyme neuroborreliosis in patients with erythema migrans K Ogrinc, S Lotrič-Furlan, V Maraspin, L Lusa, T Cerar, E Ružič-Sabljič, ... Clinical infectious diseases 57 (4), 501-509, 2013 | 60 | 2013 |
Marco PierottiIFOMVerified email at ifom.eu
